Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock-based compensation expense

v3.22.2
Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Schedule of stock-based compensation expense [Abstract]        
Research and development options expense $ 52,438 $ 77,177 $ 128,828 $ 143,809
Total research and development expenses 52,438 77,177 128,828 143,809
General and administrative options expense 573,378 491,118 1,064,177 898,273
Stock and warrants issued to consultants and employees 473,906 275,000 890,329 1,125,900
Total general and administrative expenses 1,047,284 766,118 1,954,506 2,024,173
Total stock-based compensation expense $ 1,099,722 $ 843,295 $ 2,083,334 $ 2,167,982